Home > Research Areas > Infection
Cat. No. Product name CAS No.
DC2046 Cobicistat (GS-9350) Featured

Cobicistat (GS-9350) is a potent and selective inhibitor of CYP3A with IC50 of 30-285 nM.

1004316-88-4
DC11081 Coblopasvir

Coblopasvir (KW136, KW-136) is a novel HCV NS5A inhibitor under development for treatment of HCV infection..

1312608-46-0
DC9510 CTS-1027

CTS-1027 is a potent small molecule inhibitor of MMPs(IC50=0.4 nM/0.6 nM for MMP2/MMP13); >1,000 fold selectivity over MMP1.

193022-04-7
DC7394 Daclatasvir dihydrochloride (BMS-790052) Featured

Daclatasvir (BMS-790052) is a highly selective inhibitor of HCV NS5A with EC50 of 9-50 pM, for a broad range of HCV replicon genotypes and the JFH-1 genotype 2a infectious virus in cell culture.

1009119-65-6
DC8238 Danoprevir Featured

Danoprevir is a peptidomimetic inhibitor of the NS3/4A protease of hepatitis C virus (HCV) with IC50 of 0.2-3.5 nM, inhibition effect for HCV genotypes 1A/1B/4/5/6 is ~10-fold higher than 2B/3A.

850876-88-9
DC8908 Darunavir ethanolate Featured

Darunavir ethanolate is an HIV protease inhibitor,showed potent activity against COVID-19(SARS-COV-2).

635728-49-3
DC11352 Delavirdine (mesylate)

Delavirdine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that selectively inhibits HIV-1 reverse transcriptase over DNA polymerase α and δ in vitro (IC50s = 0.26, 440, and >550 μM, respectively).

147221-93-0
DC8897 Delavirdine

Delavirdine(U 90152) is a potent non-nucleoside reverse transcriptase inhibitor (NNRTI).

136817-59-9
DC10612 Delpazolid (LCB01-0371) Featured

Delpazolid (LCB01-0371) is a new oxazolidinone with cyclic amidrazone.

1219707-39-7
DC7273 Dolutegravir Featured

Dolutegravir (DTG, GSK1349572) is an integrase inhibitor(IC50= 2.7 nM), modest activity against raltegravir-resistant signature mutants Y143R, Q148K, N155H, and G140S/Q148H.

1051375-16-6
DC10250 Dolutegravir Sodium Featured

Dolutegravir is a HIV integrase inhibitor with IC50 of 2.7 nM.

1051375-19-9
DC9308 Doravirine (MK-1439) Featured

Doravirine (MK-1439) is a non-nucleoside reverse transcriptase inhibitor.

1338225-97-0
DC11409 DSM265 Featured

DSM265 is a PfDHODH inhibitor with an IC50 of 8.9 nM. DSM265 can also inhibit the growth of P. falciparum 3D7 parasites with an EC50 of 4.3 nM.

1282041-94-4
DC8485 E-64d(Aloxistatin) Featured

E-64D is an inhibitor of cathepsins B and L; also thought to inhibit calpain,showed a potent activity for COVID-19(SARS-COV-2)with EC50: MERS-COV(1.275),SARS-COV(0.760)

88321-09-9
DCAPI1479 Efavirenz

Efavirenz is a nonnucleoside HIV-1 reverse transcriptase (RT) inhibitor which selectively inhibits the glucuronidation of 3'-Azido-3'-deoxythymidine β-D-glucuronide, Sodium Salt. Studies suggest that Efavirenz binds to a distinct site of reverse transcrip

154598-52-4
DC10301 Emodepside Featured

Emodepside (PF 1022-221) is a cyclooctadepsipeptide with broad-spectrum anthelmintic activity.

155030-63-0
DC5902 Emtricitabine Featured

Emtricitabine is a nucleoside analogue which inhibits the reverse nucleoside transcriptase enzyme. Structurally this antiviral agent is similar to Lamivudine. This agent is effective at targeting HIV and HBV viruses since these viruses replicate in a reve

143491-57-0
DC4234 Etravirine

Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) of human immunodeficiency virus type 1 (HIV-1).

269055-15-4
DCAPI1011 Famciclovir (Famvir)

Famciclovir (Famvir)

104227-87-4
DC1057 Fidaxomicin (Dificid) Featured

Fidaxomicin, is an antibiotic that belongs to the class of macrocylic antibiotics.

873857-62-6
DC7824 Fosfluconazole(INN)

Fosfluconazole (INN) is a water-soluble phosphate prodrug of fluconazole

194798-83-9
DC10307 Framycetin

Framycetin (Fradiomycin B; Neomycin B) is an aminoglycoside antibiotic. It inhibits hammerhead ribozyme with a Ki of 13.5 μM.

119-04-0
Page 3 / Total 8 FirstPrevNextLastGoto